definiens: means the testosterone based transdermal gel product for the treatment of male hypogonadism and low levels of testosterone in men developed by [COMPANY] and generally referred to as Tostrex ™ testosterone geL means any technology or information developed by [COMPANY] or licensed in by [COMPANY] ( with the right to grant sub - license rights to the Licensee ) used for manufacturing or formulating the Licensed Product or in exercise of the ' rights grante~ to Licensee hereunder, including, hut not limited to : manufacturing data ; formulation or production technology ; methOds of synthesis, isolation and purification methods and other maoufacturing infonnation and any proprietary reagents and other materials required to maoufacture the Licensed Product ; and aoy data developed by [COMPANY] related to pharmacology, toxicology, pathology, clinical data, results of clinical efficacy studies, clinical effects aod indications for use of the Licensed Product . ' means the gross sales of a Licensed Product that is due, or otherwise received by, Licensee, or its Mfiliates or its Sublicensees from Third Party customers for such Licensed Product, less : ( i ) reasonable credited allowances actually granted to such l1rird Party customers for spoiled, damaged, rejected, recalled, outdated and retumed Licensed Product and for reasonable retroactive price reductions, ( ii ) the amounts of reasonable trade, quantity and cash discounts actually allowed, to the extent such trade, quantity and cash discounts are specifically allowed on account of the purchase ' of such Licensed Product, ( iii ) sales taxes, excise taxes, use taxes and import / export duties and any other government charges ( other than taxes on income ) actually due or incurred in connection with the maoufacture, use Of sales of the Licensed Product to any Third Party, and ( iv ) reasonable allowaoces, adjustments, reimbursements, discounts, chargebacks and rebates actually granted to Third Parties, including, but not limited to,, rebates given to health care organizations or other Third Parties, and aoy bona fide payment made in respect of any sales of Licensed Product to any govemmental or quasi­governmental body or agency, whether during the actual royalty period or not